Fulton Breakefield Broenniman’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$629K Buy
7,948
+236
+3% +$18.7K 0.04% 111
2025
Q1
$692K Sell
7,712
-488
-6% -$43.8K 0.05% 96
2024
Q4
$816K Sell
8,200
-228
-3% -$22.7K 0.06% 95
2024
Q3
$957K Sell
8,428
-519
-6% -$58.9K 0.07% 91
2024
Q2
$1.11M Buy
8,947
+635
+8% +$78.6K 0.08% 86
2024
Q1
$1.1M Sell
8,312
-107
-1% -$14.1K 0.08% 85
2023
Q4
$918K Sell
8,419
-1,127
-12% -$123K 0.07% 91
2023
Q3
$983K Sell
9,546
-99
-1% -$10.2K 0.09% 87
2023
Q2
$1.11M Sell
9,645
-1,528
-14% -$176K 0.09% 86
2023
Q1
$1.19M Sell
11,173
-481
-4% -$51.2K 0.1% 84
2022
Q4
$1.29M Buy
11,654
+41
+0.4% +$4.55K 0.11% 82
2022
Q3
$1M Buy
11,613
+8
+0.1% +$689 0.09% 89
2022
Q2
$1.06M Sell
11,605
-93
-0.8% -$8.48K 0.09% 94
2022
Q1
$960K Buy
11,698
+1,569
+15% +$129K 0.08% 86
2021
Q4
$776K Buy
10,129
+57
+0.6% +$4.37K 0.06% 105
2021
Q3
$757K Sell
10,072
-600
-6% -$45.1K 0.06% 91
2021
Q2
$830K Sell
10,672
-538
-5% -$41.8K 0.07% 89
2021
Q1
$825K Buy
11,210
+4,941
+79% +$364K 0.08% 85
2020
Q4
$489K Sell
6,269
-5,822
-48% -$454K 0.06% 94
2020
Q3
$957K Sell
12,091
-53
-0.4% -$4.2K 0.11% 73
2020
Q2
$896K Buy
12,144
+78
+0.6% +$5.76K 0.11% 77
2020
Q1
$886K Sell
12,066
-1,245
-9% -$91.4K 0.13% 71
2019
Q4
$1.16M Buy
13,311
+1,640
+14% +$142K 0.13% 82
2019
Q3
$937K Buy
+11,671
New +$937K 0.12% 84
2015
Q2
Sell
-10,981
Closed -$602K 126
2015
Q1
$602K Buy
10,981
+331
+3% +$18.1K 0.13% 111
2014
Q4
$577K Buy
+10,650
New +$577K 0.13% 116
2014
Q2
Sell
-11,650
Closed -$631K 131
2014
Q1
$631K Buy
11,650
+69
+0.6% +$3.74K 0.16% 115
2013
Q4
$553K Sell
11,581
-9,052
-44% -$432K 0.15% 121
2013
Q3
$937K Buy
+20,633
New +$937K 0.25% 103